Tailored Treatment for Advanced Lung Cancer?
Patients with certain genetic profile respond better to the drug Iressa than to standard chemo, study found Source: General Cancer News Articles Provided by Cancer Compass
Patients with certain genetic profile respond better to the drug Iressa than to standard chemo, study found Source: General Cancer News Articles Provided by Cancer Compass
Benign cancer, or a benign tumor, refers to potentially cancerous cells that do not seem to be growing abnormally and can be removed. Identify a variety of benign lesions, like cysts, with medicalinformation from a practicing oncologist in this free video on types of cancer. Expert: Dr. Kenneth Fink Contact: www.nhhn.org Bio: Dr. Kenneth Fink [...]
It absorbed nearly 50% of potentially damaging rays, but more study is needed, researchers say Source: General Cancer News Articles Provided by Cancer Compass
Massage, relaxation intervention produced no significant benefits, researchers say Source: General Cancer News Articles Provided by Cancer Compass
Active surveillance or watchful waiting might be sufficient treatment for patients with prostate cancer that has a low risk of progression, according to a new study published online June 18 in The Journal of the National Cancer Institute. Source: General Cancer News Articles Provided by Cancer Compass
The U.S. Food and Drug Administration today approved Jevtana (cabazitaxel), a chemotherapy drug used in combination with the steroid prednisone to treat men with prostate cancer. Jevtana is the first treatment for advanced, hormone-refractory, prostate cancer that has worsened during or after treatment with docetaxel, a commonly used [...]
The first discovery of a cancer gene marker–the BRAF oncogene for melanoma and colorectal malignancies–back in 2002 changed the way many researchers thought about cancer treatment. Rather than approach the disease based on what region of the body it stemmed from, scientists began to identify cancers in terms of their genetic signatures. Researchers [...]
Cyclosporine treatment develops higher de novo cancer risk in liver transplant patients: Researchers Researchers at Erasmus MC University Medical Centre in The Netherlands found that cyclosporine treatment is a significant risk factor for the development of de novo cancer in liver transplant patients. Full details appear in the July issue of Liver Transplantation, a journal published [...]
Abraxis BioScience, Inc. presented abstracts describing 10 trials of nanoparticle albumin bound (nab) driven chemotherapy, nab-paclitaxel (ABRAXANE for Injectable Suspension; paclitaxel albumin protein-bound particles for injectable suspension), for the treatment of breast cancer at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Source: [...]
Life Technologies Corporation (NASDAQ: LIFE) announced the creation of the Genomic Cancer Care Alliance to help people battling cancer gain access to treatment options found through analysis of their genomic information. Founding partners include Fox Chase Cancer Center, Scripps Genomic Medicine, and the Translational Genomics Research Institute (TGen).The [...]